The CTSA Pharmaceutical Assets Portal - A public-private partnership model for drug repositioning

Drug Discovery Today: Therapeutic Strategies

Volumn 8, Issue 3-4, 2011, Pages 77-83

  Marusina, Kate ^a   Welsch, Dean J ^b   Rose, Lynn ^c   Brock, Doug ^c   Bahr, Nathan ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA BASE; DRUG INDUSTRY; DRUG REPOSITIONING; FUNDING; HUMAN; PHARMACEUTICAL CARE; PUBLIC-PRIVATE PARTNERSHIP;

EID: 84862156580     PISSN: None     EISSN: 17406773     Source Type: Journal    
DOI: 10.1016/j.ddstr.2011.06.006     Document Type: Review

References (2)

1. Huang, R. et al. (2011) The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci. Transl. Med. 3, 80ps16
2. Reis, S.E. et al. (2010) Reengineering the national clinical and translational research enterprise: the strategic plan of the National Clinical and Translational Science Awards Consortium. Acad. Med. 85, 463-469